US pharmacy pricing
Where to Find the Cheapest Rotarix Price
Lowest price found · US pharmacies
$323.19/fill
for Rotarix, across the pharmacies in our data
US pharmacy prices — 1.5ml of
| Pharmacy | Discount-card price | Regular cash price | Average retail |
|---|---|---|---|
 Walgreens | $323.19Lowest | $326.19 | $415.00 |
 Costco | $330.78 | $333.78 | $415.00 |
 Kroger Pharmacy | $335.33 | $338.33 | $415.00 |
 Harris Teeter Pharmacy | $335.33 | $338.33 | $415.00 |
 CVS Pharmacy | $337.83 | $340.83 | $415.00 |
 Publix | $349.30 | $349.30 | $415.00 |
"Discount-card price" reflects a standard prescription discount card, not insurance. Prices change often — confirm at the pharmacy before filling.
Frequently asked questions
How much does Rotarix (Rotarix) cost without insurance?
At the US pharmacies in our data, the lowest listed discount-card price for Rotarix is around $323.19. Prices vary by pharmacy, dosage, and pack size, so use the table above to compare specific options near you.
Is a generic version of Rotarix available?
Generic and brand-name pricing for Rotarix is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.
How much can I expect to pay for Rotarix with my insurance plan?
The cost of Rotarix with insurance varies significantly depending on your specific plan's formulary, deductibles, and copay structure. Some plans may cover it fully, while others may require a copay or not cover it at all. It is essential to contact your insurance provider directly to understand your coverage details. If your plan does not include Rotarix, or if you have Medicare or Medicaid that does not cover it, you may be able to use alternative pharmacy savings programs to help reduce the cost. Comparing the price available through such programs against your insurance copay can help you find the most affordable option at your local pharmacy.
Is there a generic version of Rotarix?
No. Rotarix is a branded vaccine developed by GlaxoSmithKline. As of now, there is no FDA-approved generic (biosimilar) equivalent available on the market.